Nucleus Network Pty Ltd
Nucleus Network Pty Ltd
Melbourne, Victoria, Australia10 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 1/2 Study of KRRO-121 in Healthy Volunteers and Patients With UCD | Adult-onset citrullinemia type 2, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Nutritional and Metabolic Diseases, X-linked disease, arginase deficiency, argininosuccinic aciduria, brain disorder, central nervous system disorder, hereditary disease, hyperammonemia due to N-acetylglutamate synthase deficiency, inborn disorder of amino acid metabolism, inborn errors of metabolism, metabolic disease, nervous system disorder, ornithine carbamoyltransferase deficiency, urea cycle disorder | Recruiting | Phase 1 / Phase 2 | 2026-10-08 | NCT07773246 | |
| A Phase 1 Study of PVT401 in Healthy Subjects | Digestive System Diseases, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder | Recruiting | Phase 1 | 2026-09-30 | NCT07423000 | |
| Study of ECC4703 With Sulfasalazine and Pitavastatin | Digestive System Diseases, Dyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, fatty liver disease, liver disorder, metabolic disease, metabolic dysfunction-associated steatotic liver disease | Recruiting | Phase 1 | 2026-09-10 | NCT07726368 | |
| First-In-Human Study to Evaluate Single and Multiple Ascending Doses of JUV-161 in Healthy Adult Volunteers | Healthy Volunteer | Active, not recruiting | Phase 1 | 2026-08-10 | NCT06918925 | |
| A Study of GSM-779690T in Healthy Adult Participants | Alzheimer disease, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Not yet recruiting | Phase 1 | 2026-07-09 | NCT07690228 | |
| mRNA Vaccine Targeting Epstein-Barr Virus (EBV) in Healthy Young Adults | DNA Virus Infections, Epstein-Barr virus infection, Herpesviridae infectious disease, Infections, Tumor Virus Infections, viral infectious disease | Not yet recruiting | Phase 1 | 2026-04-29 | NCT07557602 | |
| Phase 1/2a Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effect on Body Weight of RN3161 as Monotherapy and in Combination With Tirzepatide in Adults With Overweight and Obesity | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Recruiting | Phase 1 / Phase 2 | 2025-11-24 | NCT07245771 | |
| A Study to Assess the Safety and Effects of the Investigational Drug BW-40202 in Healthy Volunteers | Healthy Volunteers Only | Recruiting | Phase 1 | 2025-07-25 | NCT06917482 | |
| A Phase I Randomised, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of WD-910 in Healthy Participants | Healthy Participants | Not yet recruiting | Phase 1 | 2025-04-02 | NCT06897813 | |
| A Safety and Immunogenicity Trial of the Recombinant Zoster Vaccine （CHO Cell）, LYB004 in Adults Aged 50 to 70 Years | DNA Virus Infections, Herpesviridae infectious disease, Infections, Varicella Zoster Virus Infection, chickenpox, herpes zoster, viral infectious disease | Active, not recruiting | Phase 1 | 2025-03-13 | NCT06335849 |